In Denton, patients with certain conditions now have a new treatment option. A medication has been approved for use in children as young as six with specific skin and joint diseases. This approval is for moderate to severe cases.

The treatment comes in different forms to accommodate various patient needs. Further information about this development can be found through the Denton Record-Chronicle, including details on administration and specific patient requirements.